Showing results (401-410 of 1,086) with videos related to
Sort By:
Pageof 109
Thrombosis and Haemostasis|April 26, 2013
Clopidogrel pretreatment in primary percutaneous coronary intervention: prevalence of high on-treatment platelet reactivity and impact on preprocedural patency of the infarct-related arteryJosé Luis Ferreiro, Sílvia Homs, Javier Berdejo, et al.Seminars in Arthritis and Rheumatism|May 9, 2025
Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysisAlessandra Ida Celia, Giovanni Maria Vescovo, Gianmarco Sarto, et al.Journal of Thrombosis and Thrombolysis|September 18, 2013
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patientsHenrik Wagner, Dominick J Angiolillo, Jurrien M Ten Berg, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 13, 2016
Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registryRoberta Rossini, Dominick J Angiolillo, Giuseppe Musumeci, et al.Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 3, 2022
Management of in-stent restenosisFernando Alfonso, J J Coughlan, Daniele Giacoppo, et al.Circulation|June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel studyMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.European Heart Journal|July 11, 2025
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysisGiovanni Occhipinti, Claudio Laudani, Mattia Galli, et al.Journal of the American Heart Association|September 25, 2019
Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-AnalysisLisa Q Rong, Irbaz Hameed, Arash Salemi, et al.JACC. Cardiovascular Interventions|February 11, 2022
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Antonio Greco, Giovanni Occhipinti, et al.Pageof 109